Search results for LCK

Proto-oncogene tyrosine-protein kinase LCK Phospho-Tyr192 (LCK pY192) Antibody, Abbexa, abx327088

LCK (pY192) Antibody is a Rabbit Polyclonal against LCK (pY192).

Proto-oncogene tyrosine-protein kinase LCK Phospho-Tyr505 (LCK pY505) Antibody, Abbexa, abx333053

LCK (pY505) Antibody is a Rabbit Polyclonal against LCK (pY505).

Proto-oncogene tyrosine-protein kinase LCK Phospho-Tyr394 (LCK pY394) Antibody, Abbexa, abx333050

LCK (pY394) Antibody is a Rabbit Polyclonal against LCK (pY394).

PE Anti-Lck antibody [Y123], Abcam, AB320625

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Anti-Human LCK Antibody (SAA1559), AntibodySystem, RHC19201

APC Anti-Lck antibody [Y123], Abcam, AB320626

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Anti-Lck antibody [EPR20798-107], Abcam, AB227975

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Lck antibody [EPR20798-55], Abcam, AB227976

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Lck (phospho Y191) antibody, Abcam, AB138524

Anti-Lck (phospho Y393) antibody, Abcam, AB138442